Cure8

Why This Matters

If you have Crohn’s disease, this study suggests following a Mediterranean-style diet may be linked with lower inflammation and a gentler disease course, and it could positively change the gut microbiome and metabolites.

Who Should Pay Attention

Adults with newly diagnosed Crohn’s disease; clinicians treating IBD; researchers studying diet–microbiome interactions.

Study Snapshot

Story typeResearch news
Evidence typeClinical study
Source depthFull source text

What To Know

This news item reports results from a prospective cohort study of 271 newly diagnosed Crohn’s disease patients that looked at Mediterranean diet (MED) adherence, clinical disease course, inflammatory markers, and multi-omic gut microbiota/metabolite profiles.

The article says higher MED adherence was linked with a milder disease course, lower C-reactive protein (CRP) and faecal calprotectin levels, increases in beneficial bacteria such as Faecalibacterium, and higher levels of short-chain fatty acids and plant-derived metabolites.

Lower adherence was associated with species described as potentially harmful (Escherichia coli, Ruminococcus gnavus) and higher primary bile acids and inflammatory metabolites. The authors and the news piece note that randomised controlled trials are needed to confirm whether the Mediterranean diet can be used therapeutically for Crohn’s disease.

Keep In Mind

Observational cohort data show associations, not proof of causation. The study authors recommend randomised controlled trials before changing clinical practice.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Publicationemjreviews.com
Indexed viaBing News
Source typeResearch news
PublishedJan 25, 2025, 1:59 AM
Content availableFull source text

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →